NovoCure Ltd (NVCR)
12.94
+0.20
(+1.57%)
USD |
NASDAQ |
May 02, 10:19
NovoCure Max Drawdown (5Y): 95.07% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.07% |
March 31, 2024 | 95.07% |
February 29, 2024 | 95.07% |
January 31, 2024 | 95.07% |
December 31, 2023 | 95.07% |
November 30, 2023 | 95.07% |
October 31, 2023 | 94.40% |
September 30, 2023 | 92.84% |
August 31, 2023 | 91.75% |
July 31, 2023 | 85.53% |
June 30, 2023 | 82.14% |
May 31, 2023 | 74.98% |
April 30, 2023 | 74.98% |
March 31, 2023 | 74.98% |
February 28, 2023 | 74.91% |
January 31, 2023 | 74.91% |
December 31, 2022 | 74.91% |
November 30, 2022 | 74.91% |
October 31, 2022 | 74.91% |
September 30, 2022 | 74.91% |
August 31, 2022 | 74.91% |
July 31, 2022 | 74.91% |
June 30, 2022 | 74.91% |
May 31, 2022 | 74.32% |
April 30, 2022 | 73.34% |
Date | Value |
---|---|
March 31, 2022 | 73.34% |
February 28, 2022 | 73.34% |
January 31, 2022 | 73.34% |
December 31, 2021 | 75.45% |
November 30, 2021 | 76.17% |
October 31, 2021 | 78.30% |
September 30, 2021 | 78.30% |
August 31, 2021 | 78.30% |
July 31, 2021 | 78.83% |
June 30, 2021 | 78.83% |
May 31, 2021 | 78.83% |
April 30, 2021 | 78.83% |
March 31, 2021 | 78.83% |
February 28, 2021 | 78.83% |
January 31, 2021 | 78.83% |
December 31, 2020 | 78.83% |
November 30, 2020 | 78.83% |
October 31, 2020 | 78.83% |
September 30, 2020 | 78.83% |
August 31, 2020 | 78.83% |
July 31, 2020 | 78.83% |
June 30, 2020 | 78.83% |
May 31, 2020 | 78.83% |
April 30, 2020 | 78.83% |
March 31, 2020 | 78.83% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.34%
Minimum
Jan 2022
95.07%
Maximum
Nov 2023
79.98%
Average
78.83%
Median
May 2019
Max Drawdown (5Y) Benchmarks
AtriCure Inc | 74.05% |
NeuroMetrix Inc | 99.78% |
Repligen Corp | 64.79% |
Teleflex Inc | 59.09% |
Perspective Therapeutics Inc | 91.70% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -30.17 |
Beta (5Y) | 0.4954 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.67% |
Historical Sharpe Ratio (5Y) | -0.3643 |
Historical Sortino (5Y) | -0.6853 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.70% |